Welcome to our dedicated page for Spartacus Acqsn SEC filings (Ticker: TMTSU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Spartacus Acqsn's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Spartacus Acqsn's regulatory disclosures and financial reporting.
Spartacus Acquisition Corp. II is allowing investors to trade its Class A ordinary shares and warrants separately from the units sold in its initial public offering, starting April 2, 2026. Each unit currently consists of one Class A share and one-third of a redeemable warrant.
Each whole warrant entitles the holder to buy one Class A ordinary share at $11.50 per share, and only whole warrants will trade after separation. Units will continue to trade under the symbol TMTSU, while separated Class A shares and warrants are expected to trade on Nasdaq as TMTS and TMTSW, respectively.
Spartacus Acquisition Corp. files its annual report describing a newly formed Cayman Islands SPAC focused on completing a business combination in any industry. The company completed an IPO of 23,000,000 units at $10.00 each, placing $230,000,000 in a Nasdaq-qualifying trust account.
The SPAC has until February 12, 2028 to close a business combination or redeem public shares for cash held in the trust. Sponsor founder shares bought at a nominal price and 4,125,000 private placement warrants create potential dilution, amplified by anti-dilution protections on Class B shares.
The report explains redemption mechanics, limits on large redemptions, possible extensions of the combination period, and options to use equity, debt or additional financings. It highlights conflicts of interest, competition for deals, and geopolitical and market risks that could affect the search for a target and post-merger share performance.
RP Investment Advisors LP and affiliated funds filed a Schedule 13G disclosing shared voting and dispositive power over Units of Spartacus Acquisition Corp. II. The filing shows 1,250,000 Units (5.4%) attributable to RP Investment Advisors LP and additional holdings by affiliated funds: 737,000 Units (3.2%), 148,150 Units (0.6%), 272,250 Units (1.2%), and 92,600 Units (0.4%).
The percentages are calculated from 23,000,000 Units outstanding as of February 12, 2026, each Unit consisting of one Class A ordinary share and one-third of one redeemable warrant. The filing is a joint statement and notes that RP Investment Advisors LP is the investment advisor to the funds and may be deemed to beneficially own the securities.
Spartacus Acquisition Corp. II reports that Harraden-related parties beneficially own 1,500,000 shares of Class A common stock, representing 6.52% of the class.
The filing states these shares carry shared voting power and shared dispositive power of 1,500,000 shares among Harraden entities and that the ownership is reported by Harraden Adviser, Harraden GP, Harraden LLC, several Harraden funds, and Frederick V. Fortmiller, Jr.
Spartacus Acquisition Corp., a blank check company, reported that it completed its initial public offering of 23,000,000 units at $10.00 per unit, raising gross proceeds of $230,000,000. Each unit includes one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50 per share.
At the same time, the sponsor bought 4,125,000 private placement warrants for $4,125,000, also exercisable at $11.50 per share. In total, $230,000,000, or $10.00 per public share, was placed into a U.S. trust account to fund a future business combination. The audited balance sheet shows total assets of $231,977,563, including $230,000,000 in the trust and $1,962,363 of cash, alongside 23,000,000 Class A shares classified as redeemable and 7,666,667 Class B founder shares outstanding.
Spartacus Acquisition Corp. II completed its initial public offering of 23,000,000 units at $10.00 per unit, including full exercise of the 3,000,000-unit over-allotment, raising gross proceeds of $230,000,000. Each unit includes one Class A ordinary share and one-third of a redeemable warrant, with each whole warrant exercisable at $11.50 per share.
The company also sold 4,125,000 private placement warrants to its sponsor at $1.00 per warrant, adding $4,125,000. In total, $230,000,000 of IPO and private placement proceeds, including $2,300,000 of deferred underwriting discount, was deposited into a U.S.-based trust account to fund a future business combination within 24 months. The filing also reports the appointment of three independent directors, committee assignments, and adoption of amended and restated governing documents in connection with the IPO.